By "number of companies" I assume you're also talking about closed-end funds. True, many use leverage, and it can enhance gains and losses in a big way.
I guess I've been so thoroughly trained by the biotech sector that I see the risks in high-yield investing as (relatively) trivial. Plus I'm planning on keeping a portfolio of between 15 and 20 of these guys, as opposed to the 5 or 6 stocks I usually keep in my biotech portfolio.
Would be interested to hear your recommendations. I am really, really interested in ex-US recommendations, if you've got any.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.